Interestingly, STAT3 activation has been detected in ∼47% of ALK negative ALCL [21], and JAK inhibitor sensitivity was correlated with the STAT3 phosphorylation status independently of JAK1/STAT3 mutations [22]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.